Here, we report on the discovery of a melanoma-associated lncRNA that we named ‘T-RECS’, and that is significantly upregulated in NRAS-/BRAF-mutated cell lines and patient tumors compared to normal/non-malignant cells or tissues. This evidence concerns the gene NRAS and melanoma.